ArticleCells2022

The EXTREME Regimen Associating Cetuximab and Cisplatin Favors Head and Neck Cancer Cell Death and Immunogenicity with the Induction of an Anti-Cancer Immune Response.

Justine De Azevedo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.